China Pharma Stock Forecast, Price & News

-0.12 (-14.91 %)
(As of 04/15/2021 12:00 AM ET)
Today's Range
Now: $0.69
50-Day Range
MA: $0.45
52-Week Range
Now: $0.69
Volume1.80 million shs
Average Volume2.97 million shs
Market Capitalization$31.22 million
P/E RatioN/A
Dividend YieldN/A
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. was founded in 1993 and is based in Haikou, the People's Republic of China.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Previous SymbolNYSEMKT:CPHI
Year FoundedN/A



Sales & Book Value

Annual Sales$10.92 million
Book Value$0.21 per share


Net Income$-20,700,000.00
Net Margins-185.75%


Market Cap$31.22 million
Next Earnings Date5/21/2021 (Estimated)
OptionableNot Optionable


Airnov Made Its Debut at CPhI China
January 12, 2021 |  markets.businessinsider.com
China Pharma Holdings
January 10, 2021 |  fool.com
China Pharma Holdings, Inc.
November 8, 2020 |  reuters.com
China Pharma Holdings Inc.
June 24, 2020 |  www.barrons.com
China Pharma Q1 Net Loss Widens - Quick Facts
May 15, 2020 |  www.nasdaq.com
See More Headlines


Overall MarketRank

0.85 out of 5 stars

Medical Sector

1162nd out of 2,021 stocks

Pharmaceutical Preparations Industry

521st out of 772 stocks

Analyst Opinion: 0.0Community Rank: 3.4Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
-0.12 (-14.91 %)
(As of 04/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CPHI News and Ratings via Email

Sign-up to receive the latest news and ratings for CPHI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

China Pharma (NYSEAMERICAN:CPHI) Frequently Asked Questions

What stocks does MarketBeat like better than China Pharma?

Wall Street analysts have given China Pharma a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but China Pharma wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting China Pharma?

China Pharma saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 1,630,000 shares, an increase of 1,114.6% from the March 15th total of 134,200 shares. Based on an average daily volume of 3,090,000 shares, the days-to-cover ratio is currently 0.5 days. Currently, 7.4% of the company's stock are sold short.
View China Pharma's Short Interest

When is China Pharma's next earnings date?

China Pharma is scheduled to release its next quarterly earnings announcement on Friday, May 21st 2021.
View our earnings forecast for China Pharma

How were China Pharma's earnings last quarter?

China Pharma Holdings, Inc. (NYSEAMERICAN:CPHI) released its earnings results on Wednesday, August, 15th. The company reported ($0.02) earnings per share (EPS) for the quarter. The company had revenue of $3.17 million for the quarter. China Pharma had a negative trailing twelve-month return on equity of 240.91% and a negative net margin of 185.75%.
View China Pharma's earnings history

Who are China Pharma's key executives?

China Pharma's management team includes the following people:
  • Ms. Zhilin Li, Pres, CEO, Chairman & Interim CFO (Age 68, Pay $241.6k)
  • Sam Hsing, Corp. VP
  • Ms. Diana Huang, BOD Sec. & IRO

Who are some of China Pharma's key competitors?

What other stocks do shareholders of China Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other China Pharma investors own include iBio (IBIO), Biocept (BIOC), Dynavax Technologies (DVAX), Inovio Pharmaceuticals (INO), Heat Biologics (HTBX), Jaguar Health (JAGX), NovaBay Pharmaceuticals (NBY), AbbVie (ABBV), Celsion (CLSN) and Micron Technology (MU).

What is China Pharma's stock symbol?

China Pharma trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CPHI."

How do I buy shares of China Pharma?

Shares of CPHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is China Pharma's stock price today?

One share of CPHI stock can currently be purchased for approximately $0.69.

How much money does China Pharma make?

China Pharma has a market capitalization of $31.22 million and generates $10.92 million in revenue each year.

How many employees does China Pharma have?

China Pharma employs 237 workers across the globe.

What is China Pharma's official website?

The official website for China Pharma is www.chinapharmaholdings.com.

Where are China Pharma's headquarters?

China Pharma is headquartered at 2Nd Floor, No. 17, Jinpan Road, Haikou, HAIKOU, HAN 570216, China.

How can I contact China Pharma?

China Pharma's mailing address is 2Nd Floor, No. 17, Jinpan Road, Haikou, HAIKOU, HAN 570216, China. The company can be reached via phone at 8689866811730 or via email at [email protected]

This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.